P/E của cổ phiếu DHR là bao nhiêu?

DANAHER CORPORATION (DHR) hiện giao dịch ở mức P/E 34.44 lần.

ROE của cổ phiếu DHR là bao nhiêu?

DANAHER CORPORATION có tỷ suất lợi nhuận trên vốn chủ sở hữu (ROE) 7.61%.

Tỷ suất cổ tức của DHR là bao nhiêu?

DANAHER CORPORATION có tỷ suất cổ tức 0.73%.

Điểm chất lượng (Quality Score) của DHR là bao nhiêu?

AI của chúng tôi đánh giá chất lượng tài chính tổng thể của DHR ở mức 54/100, dựa trên khả năng sinh lời, tăng trưởng, nợ và độ ổn định lợi nhuận.

Bây giờ có nên mua cổ phiếu DHR không?

Điểm AI Timing của DHR là 89/100, thể hiện mức độ hấp dẫn tương đối của giá hiện tại theo tín hiệu kỹ thuật và momentum — nên cân nhắc cùng điểm chất lượng và kế hoạch đầu tư của bạn.

Cổ phiếu DHR thuộc ngành nào?

DANAHER CORPORATION được xếp vào ngành Healthcare >> Diagnostics & Research trên sàn NYSE

Cổ phiếu DHR (NYSE) | DANAHER CORPORATION

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-06-30)

DHR AI Analysis Summary

Our AI summary for DHR: DANAHER CORPORATION (NYSE), Healthcare >> Diagnostics & Research sector. The stock currently trades at a P/E of 34.44, ROE of 7.61%, a dividend yield of 0.73%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

DHR

DANAHER CORPORATION

US:NYSE STOCK Healthcare >> Diagnostics & Research

USD 194.98

-1.19 (-0.61%) Day Change

Watchlist Portfolio Compare Chart

34.44

P/E

0.51

D/E

7.6%

ROE

4.3%

ROA

0.73%

Div Yield

-1.85

PEG

DANAHER CORPORATION
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 194.98 Price -1.19 (-0.61%) Day Change	NEWS SCORE: N/A

DHR Chất lượng tổng thể của cố phiếu Không tốt lắm ( Chất lượng = 54) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Khá , ...

Yếu tố Chất lượng

44%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	2239
Magic Formula Rank by ROE	2239
Magic Formula Rank by ROIC	2595
Price	194.98
PBV / Sector	2.62 / -29.69
Earning Per Share	5.66

PE / Sector	34.44 / 48.18
PEG or PE/Growth / Sector	-1.85 / 1.64
Average 1M Daily Value	1,161.39 M GREAT
Average 1W Daily Value	1,099.64 M GREAT

Yếu tố Kỹ thuật

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

54%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

64%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	15.95 / 13.01 GOOD
NPM Average (%) / Sector	18.78 / 7.90 GREAT
NPM Change Average (%) / Sector	-11.47 / -6.69
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	4.33 / 11.73
ROA Average (%) / Sector	5.57 / -87.10
ROA Change Average (%) / Sector	-14.63 / 167.77
ROE (%) / Sector	7.61 / -89.83
ROE Average (%) / Sector	9.13 / -2.30
ROE Change Average (%) / Sector	-12.89 / -47.20
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

41%

Dividend (%) / Sector	0.73 / 0.18
Dividend Average (%) / Sector	0.52 / 1.19
Dividend Change Average (%) / Sector	17.80 / 4.52 GOOD

Chi tiết đăng ký

Analyze Date	2026-08-01 07:59:43
Symbol	DHR
Name	DANAHER CORPORATION
Sector	Healthcare >> Diagnostics & Research
Market	NYSE
Listed Shares	702.99 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	137,904.77 / 38,081.42

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2200 Pennsylvania Avenue N.W., Washington, DC, United States, 20037-1701

Phone: 202 828 0850

Website: https://www.danaher.com

Employees: 58,000

Sector: Healthcare >> Diagnostics & Research

Description: Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.